ILMN - Illumina Inc Stock Price, Fair Value and News

118.98USD+1.05 (+0.89%)Market Closed

Market Summary

USD118.98+1.05

Market Closed

0.89%

ILMN Alerts

Big fall in earnings (Y/Y)

Losses in recent quarter

ILMN Stock Price

View Fullscreen

ILMN RSI Chart

ILMN Valuation

Market Cap

19.0B

Price/Earnings (Trailing)

-14.69

Price/Sales (Trailing)

4.22

EV/EBITDA

-21.3

Price/Free Cashflow

51.79

ILMN Price/Sales (Trailing)

ILMN Profitability

Operating Margin

61.35%

EBT Margin

-25.54%

Return on Equity

-22.5%

Return on Assets

-12.85%

Free Cashflow Yield

1.93%

ILMN Fundamentals

ILMN Revenue

Revenue (TTM)

4.5B

Rev. Growth (Yr)

-1.01%

Rev. Growth (Qtr)

-4.1%

ILMN Earnings

Earnings (TTM)

-1.3B

Earnings Growth (Yr)

-4.3K%

Earnings Growth (Qtr)

28.41%

Breaking Down ILMN Revenue

Last 7 days

-4.6%

Last 30 days

-6.9%

Last 90 days

-17.9%

Trailing 12 Months

-40.4%

How does ILMN drawdown profile look like?

ILMN Financial Health

Current Ratio

1.75

ILMN Investor Care

Shares Dilution (1Y)

0.76%

Diluted EPS (TTM)

-8.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	4.5B	0	0	0
2023	4.4B	4.5B	4.5B	4.5B
2022	4.7B	4.7B	4.7B	4.6B
2021	3.5B	4.0B	4.3B	4.5B
2020	3.6B	3.4B	3.2B	3.2B
2019	3.4B	3.4B	3.5B	3.5B
2018	2.9B	3.1B	3.2B	3.3B
2017	2.4B	2.5B	2.6B	2.8B
2016	2.3B	2.3B	2.4B	2.4B
2015	2.0B	2.1B	2.1B	2.2B
2014	1.5B	1.6B	1.7B	1.9B
2013	1.2B	1.3B	1.3B	1.4B
2012	1.0B	1.0B	1.1B	1.1B
2011	993.1M	1.1B	1.1B	1.1B
2010	692.7M	743.1M	822.0M	902.7M
2009	0	604.3M	635.3M	666.3M
2008	0	0	0	573.2M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Illumina Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 05, 2024	rollins carissa	sold (taxes)	-15,585	127	-122	svp, chief information officer
Mar 28, 2024	ullem scott b.	acquired	22,442	137	163	-
Mar 05, 2024	thaysen jacob	acquired	-	-	29,702	chief executive officer
Mar 05, 2024	pegels kevin carl	acquired	-	-	5,569	chief of global operations
Mar 05, 2024	goswami joydeep	acquired	-	-	5,569	svp, chief financial officer
Mar 05, 2024	dadswell charles	acquired	-	-	6,683	svp, general counsel
Mar 05, 2024	rollins carissa	acquired	-	-	5,569	svp, chief information officer
Mar 05, 2024	leckman patricia	acquired	-	-	7,054	svp, chief people officer
Mar 05, 2024	reeves kathryne gambrell	acquired	-	-	5,569	svp, chief marketing officer
Mar 05, 2024	barnard steven	acquired	-	-	5,792	svp, chief technology officer

Which funds bought or sold ILMN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 03, 2024	Carson Advisory Inc.	added	13.75	24,671	227,265	0.16%
May 03, 2024	Geneos Wealth Management Inc.	reduced	-86.67	-12,698	1,922	-%
May 03, 2024	Householder Group Estate & Retirement Specialist, LLC	unchanged	-	419	14,419	-%
May 03, 2024	Alphabet Inc.	unchanged	-	-102,662	7,342,500	0.29%
May 03, 2024	C WorldWide Group Holding A/S	unchanged	-	-150,000	10,708,000	0.12%
May 03, 2024	BI Asset Management Fondsmaeglerselskab A/S	added	24.59	37,000	198,000	-%
May 03, 2024	Callan Capital, LLC	reduced	-10.06	-27,527	216,004	0.02%
May 03, 2024	Chevy Chase Trust Holdings, LLC	added	12.03	6,884,150	72,569,000	0.24%
May 03, 2024	SIGNATUREFD, LLC	added	50.06	108,657	335,061	0.01%
May 03, 2024	Larson Financial Group LLC	unchanged	-	-129	9,200	-%

Are Funds Buying or Selling ILMN?

Are funds buying ILMN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ILMN

No. of Funds

Unveiling Illumina Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.45%	18,177,520	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	13,302,678	SC 13G/A
Dec 05, 2023	baillie gifford & co	3.36%	5,332,416	SC 13G/A
Nov 20, 2023	baillie gifford & co	5.44%	8,608,269	SC 13G/A
Oct 10, 2023	vanguard group inc	11.35%	17,966,765	SC 13G/A
Feb 14, 2023	edgewood management llc	4.1%	6,478,370	SC 13G/A
Feb 09, 2023	vanguard group inc	8.28%	13,022,627	SC 13G/A
Jan 31, 2023	blackrock inc.	7.7%	12,051,653	SC 13G/A
Jan 20, 2023	baillie gifford & co	10.64%	16,743,103	SC 13G/A
Feb 14, 2022	edgewood management llc	5.6%	8,742,202	SC 13G

Recent SEC filings of Illumina Inc

View All Filings

Date Filed	Form Type	Document
May 03, 2024	10-Q	Quarterly Report
May 03, 2024	8-K/A	Current Report
May 02, 2024	8-K	Current Report
Apr 24, 2024	3	Insider Trading
Apr 24, 2024	3	Insider Trading
Apr 12, 2024	8-K	Current Report
Apr 10, 2024	4	Insider Trading
Apr 09, 2024	8-K	Current Report
Apr 04, 2024	ARS	ARS
Apr 04, 2024	DEF 14A	DEF 14A

Peers (Alternatives to Illumina Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	183.2B	23.7B	1.28%	2.05%	41.63	7.72	-8.94%	-35.91%
A	41.2B	6.7B	-2.44%	5.48%	33.34	6.12	-2.81%	-6.58%
IDXX	39.4B	3.7B	-8.21%	-2.38%	45.45	10.57	8.57%	23.94%
DGX	15.1B	9.3B	3.84%	-0.64%	17.81	1.62	-3.29%	6.68%
MEDP	12.4B	2.0B	-	93.79%	39.73	6.33	25.57%	21.62%
CRL	12.1B	4.1B	-7.04%	23.02%	25.45	2.93	3.86%	-2.39%
NTRA	11.7B	1.1B	0.48%	79.69%	-27	10.84	31.99%	20.63%
EXAS	11.5B	2.5B	-9.80%	-5.87%	-56.33	4.6	19.93%	67.26%
MID-CAP
NEOG	2.6B	929.2M	-15.40%	-30.39%	1.7K	2.83	28.93%	111.61%
GH	2.3B	563.9M	8.34%	-19.24%	-4.85	4.12	25.45%	26.76%
SMALL-CAP
CDNA	527.1M	280.3M	5.71%	21.33%	-2.77	1.88	-12.89%	-148.37%
ACRS	92.9M	31.2M	10.08%	-85.41%	-1.05	2.97	5.03%	-1.81%
APDN	61.6M	9.0M	823.08%	256.44%	-8.53	6.85	-53.31%	2.21%
AWH	39.6M	9.2M	21.97%	-30.00%	-2.37	4.33	11.85%	44.15%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Illumina Inc News

Latest updates

Illumina Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-4.1%	1,076	1,122	1,119	1,176	1,087	1,084	1,115	1,162	1,223	1,199	1,108	1,126	1,093	953	794	633	859	953	907	838	846
Cost Of Revenue	-8.8%	409	449	435	444	432	411	398	395	408	382	338	324	329	323	268	205	240	290	259	265	262
Gross Profit	-1.0%	667	674	684	732	655	673	717	767	815	818	770	802	764	630	526	428	619	662	648	573	584
Operating Expenses	-7.0%	778	837	1,438	820	719	800	4,374	1,346	631	776	1,315	615	571	497	364	332	430	394	340	368	380
S&GA Expenses	-9.1%	439	483	303	450	378	433	146	410	308	426	879	413	374	298	192	177	274	233	189	202	211
R&D Expenses	-0.4%	339	341	315	358	341	346	325	327	323	350	436	202	197	199	172	155	156	161	151	166	169
EBITDA Margin	-4.4%	-0.19*	-0.18*	-0.18*	-0.83*	-0.97*	-0.89*	-0.82*	0.05*	0.23*	0.25*	0.31*	0.28*	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.7%	18.00	19.00	19.00	19.00	20.00	9.00	6.00	6.00	6.00	13.00	14.00	16.00	19.00	16.00	11.00	11.00	11.00	11.00	11.00	15.00	15.00
Income Taxes	112.5%	17.00	8.00	-28.00	145	-81.00	-28.50	144	-102	54.00	-25.50	103	22.00	22.00	42.00	36.00	118	5.00	30.00	36.00	53.00	9.00
Earnings Before Taxes	34.9%	-109	-167	-782	-89.00	-78.00	-167	-3,672	-637	140	87.00	420	207	169	299	215	165	178	269	270	346	233
EBT Margin	-3.0%	-0.26*	-0.25*	-0.25*	-0.90*	-1.02*	-0.95*	-0.87*	0.00*	0.18*	0.20*	0.26*	0.22*	-	-	-	-	-	-	-	-	-
Net Income	28.4%	-126	-176	-754	-234	3.00	-139	-3,816	-535	86.00	113	317	185	147	257	179	47.00	173	239	234	296	233
Net Income Margin	-11.4%	-0.29*	-0.26*	-0.25*	-0.94*	-1.01*	-0.96*	-0.88*	0.00*	0.15*	0.17*	0.21*	0.19*	-	-	-	-	-	-	-	-	-
Free Cashflow	-76.3%	41.00	173	94.00	58.00	-42.00	59.00	-118	54.00	111	212	-324	209	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.7%	10,040	10,111	10,122	11,774	11,811	12,252	11,256	15,448	15,274	15,217	15,063	8,675	8,755	7,585	7,404	7,248	7,261	7,316	7,089	6,973	7,390
Current Assets	-1.0%	2,583	2,609	2,506	3,223	3,172	3,561	2,487	2,891	2,755	2,713	2,451	5,310	5,642	4,483	4,329	4,194	4,324	4,451	4,222	4,156	4,545
Cash Equivalents	5.7%	1,108	1,048	927	1,553	1,494	2,011	1,000	1,289	1,351	1,232	1,080	4,196	4,433	1,810	1,761	1,770	1,991	2,042	1,815	1,943	2,270
Inventory	-0.5%	584	587	615	617	586	568	559	518	465	431	401	380	364	372	415	435	384	359	417	420	412
Net PPE	-4.3%	964	1,007	1,040	1,069	1,082	1,091	1,068	1,055	1,034	1,024	1,009	915	915	922	910	890	890	889	875	854	852
Goodwill	0%	2,545	2,545	2,527	3,239	3,239	3,239	3,238	7,158	7,113	7,113	7,098	966	897	897	897	894	824	897	824	824	831
Current Liabilities	-6.1%	1,474	1,570	1,482	2,303	2,230	2,773	2,669	2,881	1,490	1,093	914	874	1,268	1,244	1,115	1,115	1,054	665	619	612	1,241
Long Term Debt	-	-	-	-	-	-	-	-	-	746	702	694	687	680	673	666	659	652	1,141	1,131	1,120	1,112
LT Debt, Current	-	-	-	-	750	749	748	747	746	499	-	-	-	488	511	507	503	499	-	-	-	631
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	746	702	694	687	680	673	666	659	652	1,141	1,131	1,120	1,112
Shareholder's Equity	-0.2%	5,734	5,745	5,898	6,555	6,693	6,599	6,731	10,444	10,895	10,740	10,593	5,180	4,922	4,694	4,700	4,563	4,635	4,613	4,439	4,332	4,070
Retained Earnings	-663.2%	-145	-19.00	157	911	1,145	1,142	1,281	5,097	5,632	5,485	5,372	5,055	4,870	4,723	4,466	4,287	4,240	4,067	3,828	3,594	3,298
Additional Paid-In Capital	1.1%	9,658	9,555	9,487	9,397	9,311	9,207	9,129	9,033	8,957	8,938	8,849	3,993	3,914	3,815	3,737	3,649	3,631	3,560	3,510	3,436	3,385
Accumulated Depreciation	-100.0%	-	1,138	-	-	-	962	-	-	-	796	-	-	-	678	-	-	-	-	-	-	-
Shares Outstanding	0%	159	159	158	158	158	158	157	157	157	150	148	146	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85.00
Float	-	-	-	-	26,500	-	-	-	26,100	-	-	-	60,200	-	-	-	46,200	-	-	-	48,200	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-65.6%	77.00	224	139	105	10.00	147	-52.00	125	172	282	-272	253	282	406	153	240	281	443	267	143	198
Share Based Compensation	2.1%	96.00	94.00	87.00	106	93.00	100	83.00	91.00	92.00	98.00	509	80.00	67.00	78.00	61.00	16.00	39.00	49.00	46.00	48.00	51.00
Cashflow From Investing	43.5%	-48.00	-85.00	-53.00	-37.00	-56.00	-102	-250	-165	-74.00	-	-2,448	3.00	1,376	-34.00	-65.00	-320	-135	-104	-218	79.00	988
Cashflow From Financing	229.6%	35.00	-27.00	-707	-3.00	-473	956	28.00	-5.00	21.00	-129	-394	-496	968	-331	-101	-143	-191	-115	-173	-549	-60.00
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	281	125	142	188	63.00	198	-	63.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ILMN Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Apr. 02, 2023
Revenue:
Total revenue	$ 1,076	$ 1,087
Cost of revenue:
Amortization of acquired intangible assets	48	48
Total cost of revenue	409	432
Gross profit	667	655
Operating expense:
Research and development	339	341
Selling, general and administrative	439	378
Total operating expense	778	719
Loss from operations	(111)	(64)
Other income (expense):
Interest income	12	17
Interest expense	(18)	(20)
Other income (expense), net	8	(11)
Total other income (expense), net	2	(14)
Loss before income taxes	(109)	(78)
Provision (benefit) for income taxes	17	(81)
Net (loss) income	$ (126)	$ 3
(Loss) earnings per share:
Basic (in dollars per share)	$ (0.79)	$ 0.02
Diluted (in dollars per share)	$ (0.79)	$ 0.02
Shares used in computing (loss) earnings per share:
Basic (in shares)	159	158
Diluted (in shares)	159	158
Product revenue
Revenue:
Total revenue	$ 876	$ 922
Cost of revenue:
Cost of revenue	255	285
Service and other revenue
Revenue:
Total revenue	200	165
Cost of revenue:
Cost of revenue	$ 106	$ 99

ILMN Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,108	$ 1,048
Accounts receivable, net	635	734
Inventory, net	584	587
Prepaid expenses and other current assets	256	240
Total current assets	2,583	2,609
Property and equipment, net	964	1,007
Operating lease right-of-use assets	550	544
Goodwill	2,545	2,545
Intangible assets, net	2,940	2,993
Other assets	458	413
Total assets	10,040	10,111
Current liabilities:
Accounts payable	201	245
Accrued liabilities	1,273	1,325
Total current liabilities	1,474	1,570
Operating lease liabilities	700	687
Term notes	1,490	1,489
Other long-term liabilities	642	620
Stockholders’ equity:
Common stock	2	2
Additional paid-in capital	9,658	9,555
Accumulated other comprehensive income (loss)	12	(1)
Accumulated deficit	(145)	(19)
Treasury stock, at cost	(3,793)	(3,792)
Total stockholders’ equity	5,734	5,745
Total liabilities and stockholders’ equity	$ 10,040	$ 10,111

About Illumina Inc

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

CEO	Mr. Charles E. Dadswell Esq.
WEBSITE	illumina.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	11500

Illumina Inc Frequently Asked Questions

What is the ticker symbol for Illumina Inc? What does ILMN stand for in stocks?

ILMN is the stock ticker symbol of Illumina Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Illumina Inc (ILMN)?

As of Mon May 06 2024, market cap of Illumina Inc is 18.95 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers. The fair value of Illumina Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Illumina Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ILMN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Illumina Inc a good stock to buy?

The fair value guage provides a quick view whether ILMN is over valued or under valued. Whether Illumina Inc is cheap or expensive depends on the assumptions which impact Illumina Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ILMN.

What is Illumina Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon May 06 2024, ILMN's PE ratio (Price to Earnings) is -14.69 and Price to Sales (PS) ratio is 4.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ILMN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Illumina Inc's stock?

In the past 10 years, Illumina Inc has provided -0.018 (multiply by 100 for percentage) rate of return.